InterCure (NASDAQ:INCR) Shares Down 4.4% – Time to Sell?

InterCure Ltd. (NASDAQ:INCR)’s share price fell 4.4% during trading on Monday . The company traded as low as $1.52 and last traded at $1.52. 6,040 shares were traded during trading, a decline of 80% from the average session volume of 30,784 shares. The stock had previously closed at $1.59.

InterCure Price Performance

The company has a debt-to-equity ratio of 0.15, a current ratio of 1.78 and a quick ratio of 1.15. The firm has a 50-day simple moving average of $1.45 and a two-hundred day simple moving average of $1.53.

Institutional Trading of InterCure

An institutional investor recently bought a new position in InterCure stock. Jane Street Group LLC acquired a new stake in InterCure Ltd. (NASDAQ:INCR) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 25,855 shares of the company’s stock, valued at approximately $49,000. Jane Street Group LLC owned 0.06% of InterCure as of its most recent filing with the Securities and Exchange Commission. 8.34% of the stock is currently owned by hedge funds and other institutional investors.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.